Restore Medical Appoints Chief Financial Officer; Experienced Financial Executive Christopher Geyen to Lead Financial Operations.

ST. PAUL, Minn. -- Restore Medical, Inc., maker of the innovative Pillar(R) palatal implant system, a simple, minimally-invasive treatment for mild to moderate obstructive sleep apnea (OSA) and socially disruptive snoring, today announced the appointment of Christopher Geyen, CPA, as the company's first chief financial officer (CFO). Geyen has more than 12 years of financial management experience at both private and publicly traded medical device companies, and in public accounting, and brings with him a track record of strong financial leadership.

"Chris brings broad financial management experience and financial reporting expertise to our management team," said Bob Paulson, president and CEO of Restore Medical. "Chris' experienced financial leadership with rapid growth medical device companies is an important addition to Restore Medical as we continue to grow and expand our business."

"This is an exciting time to join Restore Medical," commented Mr. Geyen. "The Pillar Procedure is a simple, clinically effective, minimally-invasive treatment that is well-positioned to serve the sleep disordered breathing market."

Prior to joining Restore Medical, Geyen served as CFO of Acorn Cardiovascular, Inc. a medical device company focused on therapies for congestive heart failure. Geyen also previously served as CFO of Urologix, Inc. (NASDAQ: ULGX), a publicly traded medical device company, and as controller of Survivalink, a privately held manufacturer of automated external defibrillators. Geyen began his career at Ernst & Young, LLP, and is a certified public accountant. Mr. Geyen graduated cum laude with a B.A. in business administration and accounting from the University of St. Thomas, St. Paul, Minnesota.

About Restore Medical and the Pillar Procedure

Restore Medical develops, manufactures and markets innovative medical devices to treat sleep disordered breathing. The Company's proprietary Pillar Palatal Implant System is the first FDA-cleared implantable treatment for snoring and mild-to-moderate OSA, and involves the insertion of three tiny woven implants into the muscle of the soft palate (the Pillar Procedure). The Pillar implants, together with the body's natural fibrotic response to the Pillar Procedure, stiffen and add structural support to the soft palate which effectively reduces or eliminates the palatal tissue flutter that causes snoring and/or collapse that can obstruct the upper airway and cause OSA. The Pillar Procedure is a one-time minimally invasive procedure that can be performed in a physician's office with the use of only topical and local anesthetics. The Pillar Palatal Implant System is sold throughout the U.S. and in various countries in Asia Pacific, Europe, and the Middle East.

For more information about Restore Medical, the Pillar Procedure, and physicians who offer the Pillar Procedure in the U.S., visit the company's web site at www.restoremedical.com or www.pillarprocedure.com.